Virtus Fund Advisers’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$68.5K Buy
+3,263
New +$75.5K 0.21% 44
2017
Q4
$36.8M Sell
1,099,946
-42,720
-4% -$1.52M 0.36% 114
2017
Q3
$42.3M Sell
1,142,666
-11,300
-1% -$424K 0.43% 106
2017
Q2
$41.5M Sell
1,153,966
-42,933
-4% -$1.4M 0.41% 117
2017
Q1
$33.6M Sell
1,196,899
-20,474
-2% -$578K 0.32% 142
2016
Q4
$35.7M Sell
1,217,373
-9,197
-0.7% -$251K 0.3% 130
2016
Q3
$33.3M Sell
1,226,570
-30,300
-2% -$685K 0.3% 128
2016
Q2
$24.1M Buy
+1,256,870
New +$26.2M 0.22% 153
2014
Q3
Sell
-1,250
Closed -$27K 1697
2014
Q2
$27K Buy
+1,250
New +$23.8K ﹤0.01% 2263

Other funds holding PAHC

Virtus Fund Advisers's PAHC Position: Q4 2024 in Review

Virtus Fund Advisers opened a new position in Phibro Animal Health (PAHC) in Q4 2024: 3,263 shares worth $68.5K. The stake represents 0.21% of the portfolio and ranks #44 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in PAHC as recently as Q4 2017.

Virtus Fund Advisers first reported a position in PAHC in Q2 2014 and has held it in 9 quarters since. The position peaked at $42.3M in Q3 2017. 172 funds tracked by Wall St. Rank hold PAHC as of Q4 2024.

  • Virtus Fund Advisers held 3,263 shares of Phibro Animal Health worth $68.5K as of Q4 2024.
  • Phibro Animal Health was a new Virtus Fund Advisers position in Q4 2024.
  • Phibro Animal Health made up 0.21% of Virtus Fund Advisers's portfolio in Q4 2024, its #44 holding.
  • Virtus Fund Advisers first reported a position in Phibro Animal Health in Q2 2014 and has held it in 9 quarters since.
  • Virtus Fund Advisers's Phibro Animal Health position peaked at $42.3M in Q3 2017.
  • 172 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2024.

Based on Virtus Fund Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.